The deal could signal that Elevance wants to build out its commercial products to hedge against volatility in Medicaid and ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Elevance Health (ELV – Research Report) received a Buy rating and a $485.00 price target from Cantor Fitzgerald analyst Sarah James yesterday. The company’s shares closed yesterday at $401.36.

Barclays raised the firm’s price target on Elevance Health (ELV) to $512 from $501 and keeps an Overweight rating on the shares post the Q4 report. The firm says it still struggles to understand ...

Gail Boudreaux; President, Chief Executive Officer, Director; Elevance Health Inc Mark Kaye; Chief Financial Officer, Executive Vice President; Elevance Health Inc Felicia Norwood; Executive Vice ...

Elevance Health Inc. shares rose as its medical costs were lower than expected in the fourth quarter, relieving investor anxiety and helping the insurer meet profit expectations. Quarterly profit was ...

Elevance Health executives told investors on Thursday ... Given the pressures on the MA program — ranging from lowered rates to ongoing elevated utilization — the insurer took a targeted ...

The market outlook is as uncertain as it gets. On January 18, Robert Pavlik, senior portfolio manager at Dakota Wealth Management, appeared in an interview on Wealth at Yahoo Finance to share his ...

KFC Serves Up New $5 Meal Deal: Here's What You Get Former WWE CEO Vince McMahon To Pay $1.7M+ For Hiding Sexual Misconduct Payments Updated Snowfall Projection Map: New Winter Storm Will Cause ...